Your browser doesn't support javascript.
loading
Visualization of a novel human monoclonal antibody against Claudin-3 for targeting ovarian cancer.
Oh, Sera; Yang, Hobin; Oh, Ho Rim; Seo, Myeung-Ryun; Lee, Chul-Hee; Kim, Young-Hwa; Choi, Jun Young; Kim, Na Young; Cheon, Gi Jeong; Kang, Keon Wook; Shin, Young Kee; Youn, Hyewon.
Afiliação
  • Oh S; Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Yang H; Laboratory of Molecular Pathology and Cancer Genomics, Research Institute of Pharmaceutical Sciences and College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
  • Oh HR; Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Seo MR; Department of Molecular Medicine and Biopharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.
  • Lee CH; Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.
  • Kim YH; Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Choi JY; R&D Center, ABION Inc., Seoul, Republic of Korea.
  • Kim NY; R&D Center, ABION Inc., Seoul, Republic of Korea.
  • Cheon GJ; Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Kang KW; Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; B
  • Shin YK; Laboratory of Molecular Pathology and Cancer Genomics, Research Institute of Pharmaceutical Sciences and College of Pharmacy, Seoul National University, Seoul, Republic of Korea.; Department of Molecular Medicine and Biopharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.
  • Youn H; Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; Cancer Imaging Center, Seoul National University Hospital, Seoul, Republic of Korea.. Electroni
Nucl Med Biol ; 114-115: 135-142, 2022.
Article em En | MEDLINE | ID: mdl-35501237
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Ovarianas Limite: Animals / Female / Humans Idioma: En Revista: Nucl Med Biol Assunto da revista: BIOLOGIA / MEDICINA NUCLEAR Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Ovarianas Limite: Animals / Female / Humans Idioma: En Revista: Nucl Med Biol Assunto da revista: BIOLOGIA / MEDICINA NUCLEAR Ano de publicação: 2022 Tipo de documento: Article